Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $33.2 million.

  • Aveanna Healthcare Holdings' Cash from Operations rose 1294.82% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.5 million, marking a year-over-year increase of 45184.89%. This contributed to the annual value of $32.6 million for FY2024, which is 4395.29% up from last year.
  • As of Q3 2025, Aveanna Healthcare Holdings' Cash from Operations stood at $33.2 million, which was up 1294.82% from $51.6 million recorded in Q2 2025.
  • In the past 5 years, Aveanna Healthcare Holdings' Cash from Operations ranged from a high of $51.6 million in Q2 2025 and a low of -$129.5 million during Q1 2022
  • In the last 5 years, Aveanna Healthcare Holdings' Cash from Operations had a median value of -$3.0 million in 2023 and averaged -$4.7 million.
  • As far as peak fluctuations go, Aveanna Healthcare Holdings' Cash from Operations crashed by 25973.32% in 2024, and later skyrocketed by 275069.1% in 2025.
  • Over the past 5 years, Aveanna Healthcare Holdings' Cash from Operations (Quarter) stood at -$32.9 million in 2021, then dropped by 22.26% to -$40.2 million in 2022, then skyrocketed by 92.53% to -$3.0 million in 2023, then soared by 546.12% to $13.4 million in 2024, then soared by 147.65% to $33.2 million in 2025.
  • Its Cash from Operations stands at $33.2 million for Q3 2025, versus $51.6 million for Q2 2025 and -$8.6 million for Q1 2025.